Actively Recruiting
Evaluating Intravenous Thrombolysis Safety and Effectiveness in Ischemic Stroke Patients Taking Direct Oral Anticoagulants The DO-IT Trial
Led by Insel Gruppe AG, University Hospital Bern · Updated on 2026-09-30
906
Participants Needed
109
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of intravenous thrombolysis IVT in adults who have had an acute ischemic stroke AIS and recently taken direct oral anticoagulants DOACs within the last 48 hours. This international, multicenter, randomized study aims to determine whether IVT combined with standard medical care leads to better outcomes at 90 days compared to standard care alone. The trial is designed as a phase 4 superiority study enrolling 906 participants at several high-volume stroke centers worldwide. Participants will be randomly assigned to one of two groups one group will receive intravenous thrombolysis using Tenecteplase or Alteplase along with the best standard medical treatment, while the other group will receive only the standard of care as per local and international guidelines. Treatment must begin within specific time windows based on stroke onset or MRI findings. The study follows current guidelines from major stroke organizations, ensuring participants receive appropriate care. During the study, participants will be monitored and assessed using the Modified Rankin Scale at 90 days to evaluate functional outcomes. Additional measures include stroke severity changes assessed by the NIH Stroke Scale within 24 hours, and quality of life questionnaires at 90 days. The study includes careful safety monitoring and long-term follow-up to fully assess treatment effects and participant well-being throughout and after the 90-day period.
CONDITIONS
Brief Title
Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
Research Team
T
Thomas Meinel, MD, PhD
F
Freschta Zipser-Mohammadzada, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here